Large gap with delayed quotes
Analysis date: 27.06.2025
Global Evaluation
Negativ
Negativ
The stock is classified in the negative zone since 17.06.2025.
Interest
Very weak
Very weak
One star since 27.06.2025.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 20.06.2025 at a price of 25.90.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Positive
Positive
The forty day technical trend is positive since 27.06.2025.
4wk Rel Perf
-2.75%
-2.75%
The four-week dividend-adjusted underperformance versus SP500 is 2.75%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 02.08.2024.
Bear Market Factor
High
High
On average, the stock has a tendency to amplify the drops in the index by 1.97%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 5.63%.
Mkt Cap in $bn
10.50
10.50
With a market capitalization >$8bn, MODERNA is considered a large-cap stock.
G/PE Ratio
1.59
1.59
A "Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings" ratio higher than 1.5 indicates that the stock's price presents a discount to growth >40% in this case.
LT P/E
-4.85
-4.85
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
7.73%
7.73%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
22
22
Over the last seven weeks, an average of 22 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
98
98
For 1% of index variation, the stock varies on average by 0.98%.
Correlation
0.29
0.29
Stock movements are strongly independent of index variations.
Value at Risk
16.25
16.25
The value at risk is estimated at USD 16.25. The risk is therefore 59.82%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
29.03.2019
29.03.2019